Table 2.
Summary of clinical, behavioral, and neuroimaging results in each participant
Participant ID | Lesion size (mm3) | Perimetry change at target (dB) | Contrast performance pretraining | Contrast performance post-training | % BOLD signal baseline | % BOLD signal change V5/hMT |
---|---|---|---|---|---|---|
H1 | 12735 | 3.04 | 92% | 91% | 0.05 | 0.16 |
H2 | 7830 | 0.14 | 74% | 80% | −0.02 | 0.10 |
H3 | 2212 | 8.75 | 84% | 82% | N/A | N/A |
H4 | 12456 | 0.00 | 65% | 70% | −0.11 | 0.09 |
H5 | 1472 | 4.04 | 59% | 76% | 0.08 | 0.17 |
H6 | 6299 | −1.50 | 57% | 61% | −0.25 | 0.27 |
H7 | 25137 | 5.06 | 57% | 71% | 0.31 | −0.01 |